These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children. Valentino PL; Ling SC; Ng VL; John P; Bonasoni P; Castro DA; Taylor G; Chavhan GB; Kamath BM Liver Int; 2014 Feb; 34(2):227-34. PubMed ID: 23829376 [TBL] [Abstract][Full Text] [Related]
28. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules. Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947 [TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887 [TBL] [Abstract][Full Text] [Related]
30. [Dynamic contrast-enhanced MR imaging and digital subtraction angiography manifestation of hepatic focal nodular hyperplasia]. Zhou JX; Li Y; Hong GB; Luo JH; Chen YT; Xu LF; Liang BL Ai Zheng; 2008 Nov; 27(11):1186-9. PubMed ID: 19000451 [TBL] [Abstract][Full Text] [Related]
31. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media]. Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050 [TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis of focal nodular hyperplasia. Role of imaging techniques. Soresi M; Carroccio A; Campagna P; Riili A; Vaglica S; Terranova A; Sesti R; Montalto G Ann Ital Med Int; 2002; 17(2):95-101. PubMed ID: 12150051 [TBL] [Abstract][Full Text] [Related]
34. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551 [TBL] [Abstract][Full Text] [Related]
35. Confluent focal nodular hyperplasia mimicking liver cancer: value of liver-specific contrast-enhanced MRI for diagnosis. Cheng YC; Chiang CM; Wu CC; Chai JW J Chin Med Assoc; 2012 Jul; 75(7):355-8. PubMed ID: 22824052 [TBL] [Abstract][Full Text] [Related]
36. Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. Lee YH; Kim SH; Cho MY; Shim KY; Kim MS AJR Am J Roentgenol; 2007 May; 188(5):W459-63. PubMed ID: 17449744 [TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced, wide-band phase-inversion power Doppler imaging of hepatic focal nodular hyperplasia. Janica J; Wojciech S; Dolorzycki S; Polakow J; Walecki J; Ladny JR; Laszewicz W Hepatogastroenterology; 2004; 51(57):705-8. PubMed ID: 15143897 [TBL] [Abstract][Full Text] [Related]
39. The role of SPIO-enhanced MRI in the detection of malignant liver lesions. Savranoglu P; Obuz F; Karasu S; Coker A; Secil M; Sagol O; Igci E; Dicle O; Astarcioglu I Clin Imaging; 2006; 30(6):377-81. PubMed ID: 17101405 [TBL] [Abstract][Full Text] [Related]
40. Hepatic focal nodular hyperplasia: the "star sign" on gadolinium-enhanced magnetic resonance angiography. Ko SF; Ng SH; Lee TY; Wan YL; Lin JW; Chen CL Hepatogastroenterology; 2002; 49(47):1377-81. PubMed ID: 12239946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]